Los Angeles Capital Management LLC Nkarta, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$7.77 - $19.44 $488,507 - $1.22 Million
-62,871 Closed
0 $0
Q1 2022

May 06, 2022
BUY
$8.66 - $14.99 $444,777 - $769,886
51,360 Added 446.18%
62,871 $715,000
Q4 2021

Feb 03, 2022
SELL
$12.79 - $26.88 $1,803 - $3,790
-141 Reduced 1.21%
11,511 $177,000
Q2 2021

Aug 05, 2021
BUY
$23.94 - $36.68 $278,948 - $427,395
11,652 New
11,652 $369,000

Others Institutions Holding NKTX

# of Institutions
129
Shares Held
66.5M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $127M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email